A stereological study on the neuroprotective actions of acute Modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse

Neuroscience Letters

Volumn 275, Issue 3, 1999, Pages 215-218

  Aguirre, J A ^a   Cintra, A ^b   Hillion, J ^b   Narvaez J A ^a   Jansson, A ^b   Antonelli, T ^c   Ferraro, L ^c   Rambert, F A ^d   Fuxe, K ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF FERRARA   (Italy)

^d Laboratoire L Lafon   (France)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Dopamine; Immunocytochemistry; Modafinil; Mouse; Parkinson's disease; Stereology; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MODAFINIL; TYROSINE 3 MONOOXYGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BENZHYDRYL COMPOUNDS; DOPAMINE; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEURONS; NEUROPROTECTIVE AGENTS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0032733249     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00706-5     Document Type: Article

References (17)

1. Bezard E., Gross C.E., Fournier M.-C., Dovero S., Bloch B., Jaber M. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp. Neurol. 155:1999;268-273.
2. David G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., Kopin I.J. Chronic parkinsonism secondary to intravenous injection of meperidine analogs. Psychiat. Res. 1:1979;249-254.
3. Duteil J., Rambert F.A., Pessonnier J., Herman J.F., Gombert R., Assous E. Central adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: studies with experimental animals. Eur. J. Pharmacol. 180:1990;49-58.
4. Ferraro L., Antonelli T., O'Connor W., Tanganelli S., Rambert F., Fuxe K. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscius rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci. Lett. 253:1998;135-138.
5. Fuxe K., Janson A.-M., Rosen L., Finman U.-B., Tanganelli S., Morari M., Goldstein M., Agnati L.F. Evidence for a protective action of the vigilance promoting drug Modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp. Brain Res. 88:1992;117-130.
6. Gundersen H.J.G., Bagger P., Bendsten T.F., Evans S., Korbo L., Marcussen N., Meller A., Nielsen K., Nyengaard B., Serensen F.B., Vesterby A., West M. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:1988;857-881.
7. Heikkila R.E., Hess A., Duvoisin R.C. Dopaminergic toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
8. Hermant J.F., Rambert F.A., Duteil J. Lack of cardiovascular effects after administration of modafinil in conscius monkeys. Fundam. Clin. Pharmacol. 5:1991;825-836.
9. + induced degeneration in vitro. Brain Res., (1999) submitted.
10. Janson A.-M., Möller A. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience. 57:1993;931-941.
11. Kunyama T., Taguchi J.-I., Kunyama K. Functional alteration in striatal cholinergic and striato-nigral GAB Aergic neurons following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration. Neurochem. Int. 16:1990;319-329.
12. McClellan K., Spencer C. Modafinil. A review of its pharmacology and clinical efficacy in the management of narcolepsy. CNS Drugs. 9:1998;311-324.
13. Mignot E., Nishino S., Guilleminault C., Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep. 17:1994;436-437.
14. Przedborski S., Jackson-Lewis V. Mechanisms of MPTP toxicity. Movements Disorders. 13:1999;35-38.
15. Tanganelli S., Fuxe K., Ferraro L., Janson A.-M., Bianchi C. Inhibitory effects of the psychoactive drug Modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Novel aspects on its mechanism of action. Schmiedeberg's Arch. Pharmacol. 345:1992;461-465.
16. Ueki A., Rosen L., Andbjer B., Agnati L.F., Hallström Å., Goiny M., Tanganelli S., Ungerstedt U., Fuxe K. Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-l in the rat. Exp. Brain Res. 96:1993;89-99.
17. Ueki A., Rosén L., Andbjer B., Finnman U.-B., Altamimi U., Janson A.M., Goldstein M., Agnati L.F., Fuxe K. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway. Exp. Brain Res. 93:1993;259-270.